On top of that, this increased expression can result in a 100–200-fold increase in the concentration of the HER2/neu receptor within tumor tissues compared to normal tissue levels, highlighting the potential role for HER2/neu as a prominent tumor-associated antigen (TAA) [9,10]. Here, ERBB2 is linked to neoplasm.